Skip to main content
BMC Surgery logoLink to BMC Surgery
. 2022 Apr 29;22:152. doi: 10.1186/s12893-022-01602-2

Circular stapling anastomosis with indocyanine green fluorescence imaging for cervical esophagogastric anastomosis after thoracoscopic esophagectomy: a propensity score-matched analysis

Yuji Shishido 1,, Tomoyuki Matsunaga 1, Masahiro Makinoya 1, Wataru Miyauchi 1, Shota Shimizu 1, Kozo Miyatani 1, Chihiro Uejima 1, Masaki Morimoto 1, Yuki Murakami 1, Takehiko Hanaki 1, Kyoichi Kihara 1, Manabu Yamamoto 1, Naruo Tokuyasu 1, Shuichi Takano 1, Teruhisa Sakamoto 1, Hiroaki Saito 2, Toshimichi Hasegawa 1, Yoshiyuki Fujiwara 1
PMCID: PMC9052471  PMID: 35488244

Abstract

Background

Thoracoscopic esophagectomy has been extensively used worldwide as a curative surgery for patients with esophageal cancer; however, complications such as anastomotic leakage and stenosis remain a major concern. Therefore, the objective of this study was to evaluate the efficacy of circular stapling anastomosis with indocyanine green (ICG) fluorescence imaging, which was standardized for cervical esophagogastric anastomosis after thoracoscopic esophagectomy.

Methods

Altogether, 121 patients with esophageal cancer who underwent thoracoscopic esophagectomy with radical lymph node dissection and cervical esophagogastric anastomosis from November 2009 to December 2020 at Tottori University Hospital were enrolled in this study. Patients who underwent surgery before the anastomotic method was standardized were included in the classical group (n = 82) and patients who underwent surgery after the anastomotic method was standardized were included in the ICG circular group (n = 39). The short-term postoperative outcomes, including anastomotic complications, were compared between the two groups using propensity-matched analysis and the risk factors for anastomotic leakage were evaluated using logistic regression analyses.

Results

Of the 121 patients, 33 were included in each group after propensity score matching. The clinicopathological characteristics of patients did not differ between the two groups after propensity score matching. In terms of perioperative outcomes, a significantly higher proportion of patients who underwent surgery using the laparoscopic approach (P < 0.001) and narrow gastric tube (P = 0.003), as well as those who had a lower volume of blood loss (P = 0.009) in the ICG circular group were observed after matching. Moreover, the ICG circular group had a significantly lower incidence of anastomotic leakage (39% vs. 9%, P = 0.004) and anastomotic stenosis (46% vs. 21%, P = 0.037) and a shorter postoperative hospital stay (30 vs. 20 days, P < 0.001) than the classical group. According to the multivariate analysis, the anastomotic method was an independent risk factor for anastomotic leakage after thoracoscopic esophagectomy (P = 0.013).

Conclusions

Circular stapling anastomosis with ICG fluorescence imaging is effective in reducing complications such as anastomotic leakage and stenosis.

Keywords: Esophageal cancer, Thoracoscopic esophagectomy, Cervical esophagogastric anastomosis, Indocyanine green fluorescence imaging, Circular stapling anastomosis, Anastomotic leakage, Anastomotic stenosis, Propensity score matching

Background

Esophageal cancer is the ninth most commonly diagnosed cancer worldwide and the sixth most common cause of cancer-related mortality [1]. Esophagectomy is the mainstay of treatment for resectable esophageal cancer. Thoracoscopic esophagectomy was first reported by Cuschieri et al. in 1992 [2] and has been used worldwide to a large extent as a curative surgery for esophageal cancer. It was reported to reduce the incidence of respiratory complications compared with open esophagectomy in a randomized controlled trial [3]. However, complications, including anastomotic leakage and stenosis, are a major cause of concern. At our institution, thoracoscopic esophagectomy was initially performed in November 2009 and this procedure has been standardized; however, the anastomotic method was not standardized until June 2018. In fact, various anastomotic methods, such as hand-sewn, triangulating [4], circular stapling, and Collard anastomosis [5], have been performed, but the complication rate of anastomosis has not reduced.

A systematic review reported that indocyanine green (ICG) fluorescence imaging could be an important adjunct tool for reducing anastomotic leakage following esophagectomy [6]. ICG is a water-soluble near-infrared phosphor that has immediate and long-term safety [7, 8]. ICG fluorescence imaging is a simple evaluation method. In a recent robot-assisted surgery, high-resolution near-infrared images were obtained by employing the Firefly system with the da Vinci Xi surgical robot (Intuitive Surgical Inc., Sunnyvale, California). Therefore, in order to assess the blood flow in the gastric tube during esophagectomy reconstruction, the use of ICG fluorescence imaging was standardized at our institution in July 2018. In addition, the anastomotic method was standardized to circular stapling anastomosis because it is simple and applicable to nearly all cases, including those with a short remnant esophagus.

This study aimed to evaluate the efficacy of circular stapling anastomosis with ICG fluorescence imaging for cervical esophagogastric anastomosis after thoracoscopic esophagectomy by comparing the short-term outcomes before and after the anastomotic method was standardized via a propensity-matched analysis.

Methods

Patients

Altogether, 145 patients with esophageal cancer who underwent thoracoscopic esophagectomy with radical lymph node dissection between November 2009 and December 2020 at Tottori University Hospital were included in this study. Among them, 19, 2, and 3 patients who underwent reconstruction using the jejunum or colon, pharyngeal gastric tube anastomosis caused by the simultaneous duplication of hypopharyngeal cancer, and two-stage reconstruction, respectively, were excluded. Finally, 121 patients were enrolled in this study (Fig. 1). Patients who underwent surgery until June 2018, i.e., before the standardization of the anastomotic method, were included in the classical group, and those who underwent surgery from July 2018, i.e., after the standardization of the anastomotic method, were included in the ICG circular group. The clinicopathological findings were determined as per the Japanese Classification of Esophageal Cancer (11th edition) [910]. This study was approved by the institutional review board of Tottori University School of Medicine (20A234), and the requirement for informed consent was waived.

Fig. 1.

Fig. 1

Patient selection for the evaluation of cervical esophagogastric anastomosis after thoracoscopic esophagectomy

Surgical procedure

All patients underwent thoracoscopic subtotal esophagectomy with mediastinal lymph node dissection in the prone position under right pneumothorax, and robot-assisted esophagectomy has been used since February 2020. After completion of the thoracic procedure, patients were repositioned in the supine position, and cervical and abdominal procedures were simultaneously initiated. Cervical lymph node dissection was not performed in patients with lower thoracic or abdominal esophageal cancer without cervical or upper mediastinal lymph node metastasis. Abdominal procedures, such as laparotomy, hand-assisted laparoscopic surgery, and complete laparoscopy for abdominal lymph node dissection, were performed. Patients who performed complete laparoscopy underwent laparotomy by making an incision of 8 cm in the upper abdomen after completing abdominal lymph node dissection, and the gastric tube was created under direct visualization in all cases. We created the gastric tube with a wide or narrow shape; the wide gastric tube is a method of resecting the stomach just below the esophagogastric junction, and the narrow gastric tube is a method of resecting the lesser curvature of the stomach so that the diameter of the gastric tube is approximately 3.5 cm. It was then pulled up to the neck through the retrosternal or posterior mediastinal route, and esophagogastric anastomosis was performed on the left side of the neck. In the classical group, before the anastomosis method was standardized, additional Kocher mobilization was performed as required for use until the area with good visual blood flow as the reconstructed gastric tube.

ICG circular anastomosis method

The ICG circular anastomosis approach was used as follows: After the gastric tube was created, ICG at a dose of 10 mg/body was administered intravenously, and ICG fluorescence imaging of the blood flow in the gastric tube was assessed using the PhotoDynamic Eye (Hamamatsu Photonics, Hamamatsu, Japan) or the Firefly system, which was integrated with the da Vinci Xi surgical robot (Intuitive Surgical Inc., Sunnyvale, California). The reconstructed gastric tube was used until the site where the wall of the gastric tube had a uniform contrast within 20 s after contrasting the right gastroepiploic artery with ICG, as reported by Noma et al. [11] (Fig. 2a, b). After the gastric tube was pulled up to the neck, end-to-side esophagogastric anastomosis was performed on the posterior wall of the gastric tube using a 25-mm DST Series EEA circular stapler (Medtronic, Minneapolis, Minnesota) (Fig. 2c). The stump of the gastric tube was sectioned and closed using the Signia stapling system with a 60-mm purple cartridge (Medtronic, Minneapolis, Minnesota) (Fig. 2d). The staple line was lastly buried.

Fig. 2.

Fig. 2

Procedures in indocyanine green (ICG) circular anastomosis. a The right gastroepiploic artery was contrasted with ICG; b The site where the wall of the gastric tube had a uniform contrast with ICG; c End-to-side esophagogastric anastomosis was performed on the posterior wall of the gastric tube using a 25-mm DST Series EEA circular stapler; d The stump of the gastric tube was sectioned and closed using the Signia stapling system with a 60 mm purple cartridge

Definition of perioperative complications

Anastomotic leakage was defined as saliva leakage from the cervical wound, contrast leakage outside the gastrointestinal tract on gastrointestinal series, and abnormal air or fluid accumulation around the site of anastomosis on computed tomography (CT) scan. A routine gastrointestinal series was performed on postoperative day 7; oral intake was initiated on postoperative day 8 for patients who experienced no problems in the postoperative course. This protocol maintained as is during the study period. Anastomotic stenosis was defined as cases in which an endoscope of 9.0 mm diameter could not pass through the anastomosis and balloon dilation was required during endoscopy for postoperative dysphagia. Pneumonia was defined as the appearance of consolidation on chest radiography or CT scan and the detection of bacteria on sputum culture. Recurrent nerve paralysis was assessed by an otolaryngologist on postoperative day 6 or 7 via laryngoscopy. The follow-up period for postoperative complications was 1 year postoperatively for anastomotic stenosis and until postoperative day 30 for other complications.

Statistical analysis

Continuous data were presented as mean ± standard deviation or median with quartiles, as indicated. The Mann–Whitney U-test and the χ2 test were used to evaluate differences in continuous and categorical variables, respectively. A propensity-matched analysis was conducted using the logistic regression model and covariates such as age, sex, histological type, tumor location, clinical stage, and presence or absence of neoadjuvant chemotherapy. Univariate and multivariate logistic regression analyses were used to identify the risk factors for anastomotic leakage. Variables that were considered statistically significant in the univariate analysis were used for the multivariate analysis. P values of < 0.05 indicated statistically significant differences, and the Statistical Package for the Social Sciences software version 25 (IBM SPSS Inc., Chicago, Illinois) was used for statistical analyses.

Results

Characteristics of patients

Of 121 patients, 82 were included in the classical group and 39 in the ICG circular group before matching. Next, 33 patients were included in each group after matching (Fig. 1). Table 1 shows the clinicopathological characteristics of patients before and after matching. Before matching, significant differences were noted in terms of the American Society of Anesthesiologists physical status (ASA-PS) score (P = 0.021) and histological type (P = 0.009). However, after matching, the background characteristics did not significantly differ between the two groups.

Table 1.

Characteristics of patients

Before matching After matching
Classical group ICG circular group P value Classical group ICG circular group P value
(n = 82) (n = 39) (n = 33) (n = 33)
Age (years) 0.892 0.872
Median (quartiles) 66 (61–72) 66 (61–71) 65 (61–73) 67 (63–73)
Sex 0.914 0.282
 Male 70 (85%) 33 (85%) 30 (90%) 27 (82%)
 Female 12 (15%) 6 (15%) 3 (9%) 6 (18%)
Body mass index (kg/m2) 21.2 ± 3.1 22.2 ± 3.3 0.083 21.8 ± 3.1 21.9 ± 3.3 0.677
Serum albumin level (g/dL) 4.2 ± 0.4 4.1 ± 0.4 0.494 4.1 ± 0.4 4.1 ± 0.4 0.985
Brinkman index 0.733 0.278
Median (quartiles) 800 (445–1000) 860 (435–1000) 820 (600–1140) 840 (405–1000)
ECOG performance status 0.586 0.601
 0 68 (83%) 34 (87%) 27 (82%) 28 (85%)
 1 12 (15%) 5 (13%) 5 (15%) 5 (15%)
 2 2 (2%) 0 (0%) 1 (3%) 0 (0%)
Comorbidity
 Diabetes 15 (18%) 4 (10%) 0.256 10 (30%) 4 (12%) 0.071
 Cardiovascular disease 10 (12%) 6 (15%) 0.628 2 (6%) 5 (15%) 0.230
 Obstructive ventilation failure 27 (33%) 13 (33%) 0.965 10 (30%) 11 (33%) 0.792
ASA-PS score 0.021 0.115
 1 11 (13%) 1 (3%) 3 (9%) 1 (3%)
 2 63 (77%) 28 (72%) 27 (82%) 23 (70%)
 3 8 (10%) 10 (26%) 3 (9%) 9 (27%)
Histological type 0.009 1.000
 Squamous cell carcinoma 78 (95%) 30 (77%) 30 (91%) 30 (91%)
 Adenocarcinoma 2 (2%) 6 (15%) 2 (6%) 2 (6%)
 Others 2 (2%) 3 (8%) 1 (3%) 1 (3%)
Tumor location 0.229 0.642
 Upper thoracic 11 (13%) 6 (15%) 5 (15%) 6 (18%)
 Middle thoracic 43 (52%) 16 (41%) 15 (46%) 16 (49%)
 Lower thoracic 24 (29%) 11 (28%) 11 (33%) 7 (21%)
 Abdominal 4 (5%) 6 (15%) 2 (6%) 4 (12%)
cT 0.405 0.667
 1 36 (44%) 16 (41%) 16 (49%) 14 (42%)
 2 14 (17%) 11 (28%) 5 (15%) 9 (27%)
 3 31 (38%) 11 (28%) 11 (33%) 9 (27%)
 4a 1 (1%) 1 (3%) 1 (3%) 1 (3%)
cN 0.224 0.420
 0 44 (54%) 28 (72%) 19 (58%) 24 (73%)
 1 17 (21%) 5 (13%) 7 (21%) 4 (12%)
 2 20 (24%) 5 (13%) 7 (21%) 5 (15%)
 3 1 (1%) 1 (3%) 0 (0%) 0 (0%)
cStage 0.296 0.393
 1 32 (39%) 14 (36%) 16 (49%) 13 (39%)
 2 19 (23%) 14 (36%) 5 (15%) 10 (30%)
 3 31 (38%) 11 (28%) 12 (36%) 10 (30%)
Neoadjuvant chemotherapy 0.974 1.000
 Absent 36 (44%) 17 (44%) 16 (49%) 16 (49%)
 Present 46 (56%) 22 (56%) 17 (52%) 17 (52%)

ECOG Eastern Cooperative Oncology Group, ASA-PS American Society of Anesthesiologists physical status

Changes in anastomotic methods and perioperative outcomes

Figure 3 presents changes in anastomotic methods for cervical esophagogastric anastomosis after thoracoscopic esophagectomy, and Table 2 depicts the perioperative outcomes in both groups. As shown in Table 2, prior to matching, a significantly higher proportion of patients underwent surgery using the laparoscopic approach (P < 0.001) and narrow gastric tube (P = 0.001) and those who had a lower volume of blood loss (P = 0.038) in the ICG circular group. After matching, the same factors indicated a significant difference. In terms of postoperative outcomes, the ICG circular group had a significantly lower proportion of patients who were observed to have anastomotic leakage (34% vs. 8%, P = 0.002) and a shorter postoperative hospital stay (29 vs. 20 days, P < 0.001) before matching. After matching, a significantly lower proportion of patients were noted to have anastomotic leakage (39% vs. 9%, P = 0.004) and stenosis (46% vs. 21%, P = 0.037) and a shorter postoperative hospital stay (30 vs. 20 days, P < 0.001) in the ICG circular group.

Fig. 3.

Fig. 3

Changes in anastomotic methods for cervical esophagogastric anastomosis after thoracoscopic esophagectomy. Changes in the classical and ICG circular groups, and the annual incidence rates of anastomotic leakage and stenosis in anastomotic methods for cervical esophagogastric anastomosis after thoracoscopic esophagectomy are shown

Table 2.

Perioperative outcomes of patients with esophageal cancer after thoracoscopic esophagectomy

Before matching After matching
Classical group ICG circular group P value Classical group ICG circular group P value
(n = 82) (n = 39) (n = 33) (n = 33)
Abdominal approach < 0.001 < 0.001
 Open 34 (42%) 0 (0%) 15 (46%) 0 (0%)
 Laparoscopic 48 (59%) 39 (100%) 18 (55%) 33 (100%)
Lymph node dissection 0.180 1.000
 Two-field 18 (22%) 13 (33%) 10 (30%) 10 (30%)
 Three-field 64 (78%) 26 (67%) 23 (70%) 23 (70%)
Route of reconstruction 0.070 0.131
 Retrosternal 68 (83%) 37 (95%) 27 (82%) 31 (94%)
 Posterior mediastinal 14 (17%) 2 (5%) 6 (18%) 2 (6%)
Shape of the gastric tube 0.001 0.003
 Wide 21 (26%) 0 (0%) 8 (24%) 0 (0%)
 Narrow 61 (74%) 39 (100%) 25 (76%) 33 (100%)
Total operative time (min) 634 ± 89 617 ± 53 0.573 638 ± 100 616 ± 51 0.753
Volume of blood loss (mL) 186 ± 219 103 ± 97 0.038 251 ± 298 93 ± 89 0.009
Postoperative complications
 Anastomotic leakage 28 (34%) 3 (8%) 0.002 13 (39%) 3 (9%) 0.004
 Anastomotic stenosis 29 (35%) 8 (21%) 0.097 15 (46%) 7 (21%) 0.037
 Pneumonia 18 (22%) 11 (28%) 0.451 8 (24%) 9 (27%) 0.778
 Recurrent nerve paralysis 14 (17%) 2 (5%) 0.070 7 (21%) 2 (6%) 0.073
 Postoperative hospital stay 29 (22–44) 20 (16–28) < 0.001 30 (25–44) 20 (17–28) < 0.001

Risk factor analyses of anastomotic leakage

Finally, the risk factors for anastomotic leakage were evaluated via propensity score matching in 66 patients. The univariate analysis indicated that the Brinkman index (P = 0.048) and anastomotic method (P = 0.008) were significantly associated with anastomotic leakage (Table 4). According to the multivariate analysis, the anastomotic method was an independent risk factor for anastomotic leakage after thoracoscopic esophagectomy (odds ratio: 5.983, 95% confidence interval (CI): 1.469–24.359, P = 0.013) (Table 3).

Table 4.

Multivariate logistic regression analyses of anastomotic leakage

OR 95% CI P value
Brinkman index (≥ 800) 3.538 0.842–14.860 0.084
Anastomotic method (classical group) 5.983 1.469–24.359 0.013

OR odds ratio, CI confidence interval

Table 3.

Univariate logistic regression analyses of anastomotic leakage

Anastomotic leakage
Absent (n = 50) Present (n = 16) OR 95% CI P value
Age (years)
 <65 20 (40%) 8 (50%) 1.500 0.484–4.651 0.483
 ≥65 30 (60%) 8 (50%) 1
Sex
 Male 42 (84%) 15 (94%) 2.857 0.329–24.795 0.341
 Female 8 (16%) 1 (6%) 1
Body mass index (kg/m2)
 <22 24 (48%) 10 (63%) 1.806 0.569–5.726 0.316
 ≥ 22 26 (52%) 6 (38%) 1
Serum albumin level (g/dL)
 <4 20 (40%) 5 (31%) 0.682 0.206–2.261 0.531
 ≥ 4 30 (60%) 11 (69%) 1
Brinkman index
 <800 24 (48%) 3 (19%) 0.250 0.063–0.986 0.048
 ≥ 800 26 (52%) 13 (81%) 1
Performance status
 0 42 (84%) 13 (81%) 0.825 0.191–3.574 0.797
 1, 2 8 (16%) 3 (19%) 1
Diabetes
 Absent 39 (78%) 13 (81%) 1.222 0.295–5.069 0.782
 Present 11 (22%) 3 (19%) 1
Cardiovascular disease
 Absent 46 (92%) 13 (81%) 0.377 0.075–1.901 0.237
 Present 4 (8%) 3 (19%)
Obstructive ventilation failure
 Absent 36 (72%) 9 (56%) 0.500 0.156–1.603 0.243
 Present 14 (28%) 7 (44%) 1
ASA-PS score
 1 3 (6%) 1 (6%) 1.044 0.101–10.806 0.971
 2, 3 47 (94%) 15 (94%) 1
Histological type
 Squamous cell carcinoma 45 (90%) 15 (94%) 1.667 0.180–15.425 0.653
 Others 5 (10%) 1 (6%) 1
Tumor location
 Ut, Mt 31 (62%) 11 (69%) 1.348 0.406–4.484 0.626
 Lt, Ae 19 (38%) 5 (31%) 1
cT
 1 21 (42%) 9 (56%) 1.776 0.570–5.531 0.322
 2, 3, 4a 29 (58%) 7 (44%) 1
cN
 Absent 33 (66%) 10 (63%) 0.859 0.267–2.764 0.798
 Present 17 (34%) 6 (38%) 1
cStage
 1 20 (40%) 9 (56%) 1.929 0.618–6.020 0.258
 2, 3 30 (60%) 7 (44%) 1
Neoadjuvant chemotherapy
 Absent 22 (44%) 10 (63%) 2.121 0.668–6.739 0.202
 Present 28 (56%) 6 (38%) 1
Abdominal approach
 Open 11 (22%) 4 (25%) 1.182 0.317–4.400 0.803
 Laparoscopic 39 (78%) 12 (75%) 1
Lymph node dissection
 Two-field 15 (30%) 5 (31%) 1.061 0.314–3.585 0.925
 Three-field 35 (70%) 11 (69%) 1
Route of reconstruction
 Retrosternal 43 (86%) 15 (94%) 2.442 0.277–21.519 0.421
 Posterior mediastinal 7 (14%) 1 (6%) 1
Shape of gastric tube
 Wide 5 (10%) 3 (19%) 2.077 0.437–9.871 0.358
 Narrow 45 (90%) 13 (81%) 1
Total operative time (min)
 <600 20 (40%) 6 (38%) 0.900 0.282–2.870 0.859
 ≥ 600 30 (60%) 10 (63%) 1
Blood loss (mL)
 <100 26 (52%) 7 (44%) 0.718 0.231–2.229 0.566
 ≥ 100 24 (48%) 9 (56%) 1
Anastomotic method
 ICG circular group 30 (60%) 3 (19%) 0.154 0.039–0.610 0.008
 Classical group 20 (40%) 13 (81%) 1

OR odds ratio, CI confidence interval, ASA-PS American Society of Anesthesiologists physical status

Discussion

This study aimed to evaluate the efficacy of circular stapling anastomosis with ICG fluorescence imaging for cervical esophagogastric anastomosis after thoracoscopic esophagectomy by comparing the short-term outcomes before and after the standardization of the anastomotic method via a propensity-matched analysis. The ICG circular group had a significantly lower rate of complications, including anastomotic leakage and stenosis, and a shorter postoperative hospital stay. Furthermore, anastomotic method was an independent risk factor for anastomotic leakage after thoracoscopic esophagectomy.

The incidence of anastomotic leakage was significantly lower in the ICG circular group than in the classical group, and anastomotic method was found to be an independent risk factor for postoperative anastomotic leakage. According to a systematic review on ICG fluorescence imaging after esophageal cancer surgery, the overall anastomotic leakage rate in patients who underwent surgery with ICG fluorescence imaging was lower than that in controls (13.5% [118/873] vs. 18.5% [86/466]) [6]. Furthermore, when anastomosis was performed at the site where good ICG perfusion was observed, the incidence of anastomotic leakage was 9.0% (67/746). In this study, anastomosis was performed at the site where good ICG perfusion was observed in all patients in the ICG circular group. Thus, the outcomes of anastomotic leakage were comparable. Honda et al. performed a systematic review comparing outcomes of anastomosis after esophagectomy between hand-sewn and mechanical anastomosis using a circular stapler [12]. Results showed that the anastomotic leakage rate with circular stapling anastomosis (6.1%, 41/668) was similar to that with hand-sewn anastomosis (6.1%, 39/640) (risk ratio [RR]: 1.02, 95% CI: 0.66–1.59, P = 0.43); compared with our results, particularly in classical group, the rate of anastomotic leakage was extremely low. The most important reason for the high anastomotic leakage rate in the classical group was that an excessive number of anastomosis methods were performed. However, in the ICG circular group, anastomosis was performed using a completely uniform technique in all cases, which may have had a substantial impact on our results. Moreover, the review by Honda et al. included studies in which intrathoracic anastomosis was performed. Thus, the outcomes of this review were not completely comparable to those of cervical esophagogastric anastomosis, and our results were acceptable. In addition, Honda et al. showed that the approach using mechanical circular stapling anastomosis considerably reduced the operative time by 15.3 min compared with that required by hand-sewn anastomosis. In our study, the total operative time tended to be shorter in the ICG circular group than in the classical group; however, it was not significant. Therefore, circular stapling anastomosis with ICG fluorescence imaging is a simple and safe method that can reduce anastomotic leakage after thoracoscopic esophagectomy.

This study showed that the incidence of anastomotic stenosis was substantially lower in the ICG circular group than in the classical group after propensity score matching. However, the anastomotic stenosis rate in the classical group after matching was extremely high at 46%, which may have had a significant impact. Honda et al., who conducted a subgroup and meta-regression analysis, showed that the stenosis rate of circular stapling anastomosis was significantly higher than that of hand-sewn anastomosis (16.9% [106/626] and 9.9% [62/629]) (RR: 1.67, 95% CI: 1.16–2.42; P = 0.006); they showed no significant differences in the anastomotic site, diameter of the circular stapler, layer, and configuration [12]. A randomized controlled trial by Hayata et al. comparing cervical esophagogastric circular stapling and triangulating stapling anastomoses after esophagectomy showed no significant difference in terms of anastomotic stenosis rate between the circular stapling group (17%, 8/47) and the triangulating stapling group (19%, 9/51) (P = 0.935) [13]. In this study, the anastomotic stenosis rate in the ICG circular group was 21%, which was similar to that noted in previous reports but was not satisfactory. Therefore, although the incidence rate of anastomotic stenosis is improving because of the standardization of anastomotic methods, it should still be further reduced.

This study had several limitations. First, this was a retrospective study with a small sample size. All relevant clinicopathological and technical factors, with the exception of the anastomotic method, should have been included in the matching factors; however, this was not practical because of the small sample size. As a result, reconstruction-related perioperative outcomes, such as abdominal approach and shape of gastric tube were not consistent between the two groups. Therefore, the outcomes of ICG circular anastomosis after standardization must be prospectively evaluated. Second, various anastomotic methods were performed in the classical group patients. Therefore, a propensity-matched analysis was performed to eliminate differences in patient characteristics and to prevent bias as much as possible.

Conclusions

Circular stapling anastomosis with ICG fluorescence imaging was found to be effective in reducing anastomotic complications for cervical esophagogastric anastomosis after thoracoscopic esophagectomy. It was particularly crucial for the anastomotic method to be standardized in this study. However, the incidence rate of anastomotic stenosis can still be improved, and this is a problem that should be addressed in the future.

Acknowledgements

The authors would like to thank Enago (www.enago.jp) for the English language review.

Abbreviations

ICG

Indocyanine green

ASA-PS

The American Society of Anesthesiologists physical status

CI

Confidence interval

RR

Risk ratio

Author contributions

Study conception: YS; study design: YS and TM; data acquisition: YS, TM, MM, WM, SS, and KM; quality control of data and algorithms: CU, MM, YM, TH, and KK; data analysis and interpretation: MY, NT, ST and TS; statistical analysis: YS; manuscript preparation: YS; manuscript editing: HS and TH; manuscript review: TM and YF; All authors read and approved the final manuscript.

Funding

The authors received no funding for this study.

Availability of data and materials

The datasets generated and analyzed during the current study are not publicly available due to difficulty in obtaining approval from all patients for the release of detailed personal data, but they are available from the corresponding author on reasonable request.

Declarations

Ethics approval and consent to participate

This study was approved by the ethical review board of Tottori University School of Medicine (20A234) and performed in accordance with the Declaration of Helsinki. The requirement of informed consent was waived the informed consent,

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Footnotes

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi: 10.3322/caac.21492. [DOI] [PubMed] [Google Scholar]
  • 2.Cuschieri A, Shimi S, Banting S. Endoscopic oesophagectomy through a right thoracoscopic approach. J R Coll Surg Edinb. 1992;37:7–11. [PubMed] [Google Scholar]
  • 3.Biere SS, van Berge Henegouwen MI, Maas KW, Bonavina L, Rosman C, Garcia JR, et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet. 2012;379:1887–92. doi: 10.1016/S0140-6736(12)60516-9. [DOI] [PubMed] [Google Scholar]
  • 4.Toh Y, Sakaguchi Y, Ikeda O, Adachi E, Ohgaki K, Yamashita Y, et al. The triangulating stapling technique for cervical esophagogastric anastomosis after esophagectomy. Surg Today. 2009;39:201–6. doi: 10.1007/s00595-008-3827-2. [DOI] [PubMed] [Google Scholar]
  • 5.Collard JM, Romagnoli R, Goncette L, Otte JB, Kestens PJ. Terminalized semimechanical side-to-side suture technique for cervical esophagogastrostomy. Ann Thorac Surg. 1998;65(3):814–7. doi: 10.1016/s0003-4975(97)01384-2. [DOI] [PubMed] [Google Scholar]
  • 6.Koyanagi K, Ozawa S, Ninomiya Y, Yatabe K, Higuchi T, Yamamoto M, et al. Indocyanine green fluorescence imaging for evaluating blood flow in the reconstructed conduit after esophageal cancer surgery. Surg Today. 2021 doi: 10.1007/s00595-021-02296-4. [DOI] [PubMed] [Google Scholar]
  • 7.Ogawa M, Kosaka N, Choyke PL, Kobayashi H. In vivo molecular imaging of cancer with a quenching near-infrared fluorescent probe using conjugates of monoclonal antibodies and indocyanine green. Cancer Res. 2009;69:1268–72. doi: 10.1158/0008-5472.CAN-08-3116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Murawa D, Polom K, Murawa P. One-year postoperative morbidity associated with near-infrared-guided indocyanine green (ICG) or ICG in conjugation with human serum albumin (ICG:HSA) sentinel lymph node biopsy. Surg Innov. 2014;21:240–3. doi: 10.1177/1553350613503737. [DOI] [PubMed] [Google Scholar]
  • 9.Japanese Classification of Esophageal Cancer. 11th ed. (I). Esophagus. 2017;14:1–36. [DOI] [PMC free article] [PubMed]
  • 10.Japanese Classification of Esophageal Cancer. 11th ed. (II and III). Esophagus. 2017;14:37–65. [DOI] [PMC free article] [PubMed]
  • 11.Noma K, Shirakawa Y, Kanaya N, Okada T, Maeda N, Ninomiya T, et al. Visualized evaluation of blood flow to the gastric conduit and complications in esophageal reconstruction. J Am Coll Surg. 2018;226:241–51. doi: 10.1016/j.jamcollsurg.2017.11.007. [DOI] [PubMed] [Google Scholar]
  • 12.Honda M, Kuriyama A, Noma H, Nunobe S, Furukawa TA. Hand-sewn versus mechanical esophagogastric anastomosis after esophagectomy: a systematic review and meta-analysis. Ann Surg. 2013;257:238–48. doi: 10.1097/SLA.0b013e31826d4723. [DOI] [PubMed] [Google Scholar]
  • 13.Hayata K, Nakamori M, Nakamura M, Ojima T, Iwahashi M, Katsuda M, et al. Circular stapling versus triangulating stapling for the cervical esophagogastric anastomosis after esophagectomy in patients with thoracic esophageal cancer: a prospective, randomized, controlled trial. Surgery. 2017;162:131–8. doi: 10.1016/j.surg.2017.01.013. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The datasets generated and analyzed during the current study are not publicly available due to difficulty in obtaining approval from all patients for the release of detailed personal data, but they are available from the corresponding author on reasonable request.


Articles from BMC Surgery are provided here courtesy of BMC

RESOURCES